Latest News for: 3 phases

Edit

Realized Cap vs. Market Cap: Cryptoquant CEO Points to Bitcoin Bear Phase

Bitcoin 07 Apr 2025
Ki Young Ju, the CEO of Cryptoquant, stated this weekend that ...
Edit

Stirling Planning Ahead: Student flats proposed and South Stirling Gateway housing phase two

The Courier 07 Apr 2025
It's all about new housing this time around - and mountain bikes ... .
Edit

China and neighbours at risk of catastrophic quakes as region enters new seismic phase, scientists say

The Independent 07 Apr 2025
Study published days before Myanmar earthquake warns region has entered sixth seismic ‘active period’ .
Edit

Lexeo Therapeutics Announces Positive Interim Phase 1/2 Data for LX2006 in Friedreich Ataxia

Enid News & Eagle 07 Apr 2025
Participants with abnormal left ventricular mass index (LVMI) at baseline achieved 25% mean reduction in LVMI by 12 months or sooner ... .
Edit

Reunion Neuroscience Presents REKINDLE, a Phase 2 Clinical Trial Evaluating RE104 for the

The Eagle-Tribune 07 Apr 2025
-- AjD is a Mental Health Condition Triggered By a Stressful Life Event; Particularly Common in People with Serious Medical Illness -- ... .
Edit

Rhythm Pharmaceuticals Announces Pivotal Phase 3 TRANSCEND Trial Meets Primary Endpoint with

The Eagle-Tribune 07 Apr 2025
-- Patients with acquired hypothalamic obesity on setmelanotide therapy (n=81) achieved mean BMI change of -16.5% compared with +3.3% for placebo (n=39) at 52 weeks (p<0.0001) -- ... .
Edit

Reunion Neuroscience Presents REKINDLE, a Phase 2 Clinical Trial Evaluating RE104 for the Treatment of ...

Nasdaq Globe Newswire 07 Apr 2025
-- AjD is a Mental Health Condition Triggered By a Stressful Life Event; Particularly Common in People with Serious Medical Illness --. -- AjD Represents an Area of Significant Unmet Need; No FDA-Approved Therapies Currently Available -- ... .
Edit

NKGen Biotech Presents Data from Phase 1/2a Clinical Trial of Troculeucel in Moderate Alzheimer’s Disease ...

Nasdaq Globe Newswire 07 Apr 2025
Moderate Alzheimer’s disease (AD) patients in the trial received the highest dose of troculeucel to date at 6 billion cells per treatment ... .
×